Article3 Biotech2020

Dehydrozingerone protects temozolomide-induced cognitive impairment in normal and C6 glioma rats besides enhancing its anticancer potential.

Nandini Pathak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.